The strength of correlation between maximum CMAP amplitude and our primary outcome measure, the MHFMS, suggests that in non-ambulatory patients with SMA the CMAP may be a robust surrogate outcome measure for assessing treatment interventions if the putative mechanism of effect is to enhance innervated muscle mass by reinnervation or other trophic effects on nerve or muscle
Chung WH, Hung SI
Hurry, a limited-time offer is available to get yours for 24% less
Preparing with structured meal plans, higher-protein nutrition strategies, and regular physical activity helps offset the return of hunger signals
P., King, R., Rowsell, R., Zwalf, O., Rathner, Y.,
Dosage calculators Before you can plot a dose, you need to know the correct dose amount